NanoString Technologies to Present at the Meeting of the Microarray Gene Expression Data Society, MGED9
About NanoString Technologies, Inc.
NanoString Technologies is an early stage company developing a patent-pending nanotechnology-based platform for high speed, highly multiplexed, single molecule identification and digital quantification. This breakthrough has the potential to become a biological operating system onto which many biomolecular analysis applications can be developed. NanoString Technologies is headquartered in Seattle, Washington. For more information, visit: www.nanostring.com.